A Phase 2 Study to Evaluate the Efficacy and Safety of Pudafensine in Vulvodynia (Provoked Vestibulodynia)

Exclusion criteria

• ✕. Infectious (e.g. recurrent candidiasis, herpes).
• ✕. Inflammatory (e.g. lichen sclerosus, lichen planus, immunobullous disorders).
• ✕. Neoplastic (e.g. Paget disease, squamous cell carcinoma).
• ✕. Neurologic (e.g. postherpetic neuralgia, nerve compression or injury, neuroma).
• ✕. Trauma (e.g. female genital cutting, obstetrical).
• ✕. Iatrogenic (e.g. postoperative, chemotherapy, radiation).
• ✕. Hormonal deficiencies (e.g. genitourinary syndrome of menopause (vulvovaginal atrophy), lactational amenorrhea).